Research‑Grade mRNA That Moves as Fast as Your Ideas Learn more about key considerations when sourcing research-grade mRNA and discover Vernal’s approach to its new research-grade mRNA manufacturing service offering. Read Article Unlocking Oral RNA Therapeutics: Overcoming Barriers to Gut-Stable…
Advancements in Biopharma Spur Innovation Christian Cobaugh, chief scientific officer and founder of Vernal Biosciences, offered PharmaTech editor Susan Haigney comments about where he believes mRNA and LNP advancements fit into the biopharm innovation landscape. Source: Pharmaceutical Technology, June 2025,…
Awakening the Giant: The Next Frontier in mRNA Therapeutics We’ve seen what mRNA can do in vaccines—but that was only the beginning. In a new article published in American Pharmaceutical Review , Vernal’s CSO Christian Cobaugh, Ph.D., outlines how mRNA…
The Evolving Needs of Therapeutic mRNA Developers Insights on the next wave of challenges mRNA innovators face as an increasing number of therapeutics move through the pipeline. Read Article Behind the Headlines Panel Discussion Christian Cobaugh, Ph.D., Vernal Biosciences founder…